Andreas Brink

973 total citations
33 papers, 632 citations indexed

About

Andreas Brink is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Andreas Brink has authored 33 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Andreas Brink's work include Carcinogens and Genotoxicity Assessment (7 papers), DNA and Nucleic Acid Chemistry (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Andreas Brink is often cited by papers focused on Carcinogens and Genotoxicity Assessment (7 papers), DNA and Nucleic Acid Chemistry (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Andreas Brink collaborates with scholars based in Switzerland, Germany and United States. Andreas Brink's co-authors include Werner K. Lutz, Axel Pähler, Helga Stopper, Simone Schadt, Ursula Lutz, Ingrid Richter, Christophe Husser, Wolfgang Völkel, J. Schlatter and Marco Kellert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Andreas Brink

33 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Brink Switzerland	14	309	112	93	91	66	33	632
Rong Lin China	16	435 1.4×	47 0.4×	50 0.5×	52 0.6×	23 0.3×	31	783
Xia Tao China	17	580 1.9×	319 2.8×	34 0.4×	112 1.2×	35 0.5×	42	921
Parvaneh Espandiari United States	19	279 0.9×	171 1.5×	101 1.1×	104 1.1×	41 0.6×	29	865
Weiwei Li China	18	449 1.5×	77 0.7×	14 0.2×	199 2.2×	53 0.8×	47	897
Sensuke Konno United States	17	338 1.1×	82 0.7×	26 0.3×	74 0.8×	13 0.2×	71	781
Angela K. Goodenough United States	14	477 1.5×	290 2.6×	28 0.3×	335 3.7×	77 1.2×	18	1.1k
Athina Zira Greece	11	275 0.9×	60 0.5×	26 0.3×	51 0.6×	27 0.4×	14	510
Yuming Wang China	18	507 1.6×	47 0.4×	19 0.2×	303 3.3×	29 0.4×	49	891
Mark A. Carfagna United States	9	137 0.4×	117 1.0×	22 0.2×	82 0.9×	21 0.3×	16	545

Countries citing papers authored by Andreas Brink

Since Specialization

Citations

This map shows the geographic impact of Andreas Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Brink more than expected).

Fields of papers citing papers by Andreas Brink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Brink. The network helps show where Andreas Brink may publish in the future.

Co-authorship network of co-authors of Andreas Brink

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Brink. A scholar is included among the top collaborators of Andreas Brink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Brink. Andreas Brink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duschmalé, Jörg, Erik Daa Funder, Steffen Schmidt, et al.. (2022). Investigating discovery strategies and pharmacological properties of stereodefined phosphorodithioate LNA gapmers. Molecular Therapy — Nucleic Acids. 29. 176–188. 5 indexed citations

Meneses‐Lorente, Georgina, Darren Bentley, Elena Guerini, et al.. (2021). Characterization of the pharmacokinetics of entrectinib and its active M5 metabolite in healthy volunteers and patients with solid tumors. Investigational New Drugs. 39(3). 803–811. 26 indexed citations

Meneses‐Lorente, Georgina, Stephen Fowler, Elena Guerini, et al.. (2021). In vitro and clinical investigations to determine the drug-drug interaction potential of entrectinib, a small molecule inhibitor of neurotrophic tyrosine receptor kinase (NTRK). Investigational New Drugs. 40(1). 68–80. 12 indexed citations

Fowler, Stephen, Andreas Brink, Yumi Cleary, et al.. (2021). Addressing Today’s Absorption, Distribution, Metabolism, and Excretion (ADME) Challenges in the Translation of In Vitro ADME Characteristics to Humans: A Case Study of the SMN2 mRNA Splicing Modifier Risdiplam. Drug Metabolism and Disposition. 50(1). 65–75. 13 indexed citations

Petzsche, Moritz Roman Hernández, Qiuyue Ma, Helen Liapis, et al.. (2020). Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease. Journal of the American Society of Nephrology. 31(12). 2773–2792. 97 indexed citations

Lenz, Barbara, Andreas Brink, Michael J. Mihatsch, et al.. (2020). Multiorgan Crystal Deposition of an Amphoteric Drug in Rats Due to Lysosomal Accumulation and Conversion to a Poorly Soluble Hydrochloride Salt. Toxicological Sciences. 180(2). 383–394. 4 indexed citations

Zeller, Andreas, Alessandro Brigo, Andreas Brink, et al.. (2019). Genotoxicity Assessment of Drug Metabolites in the Context of MIST and Beyond. Chemical Research in Toxicology. 33(1). 10–19. 9 indexed citations

Weidolf, Lars, Thomas Andersson, Joel P. Bercu, et al.. (2019). Qualification of impurities based on metabolite data. Regulatory Toxicology and Pharmacology. 110. 104524–104524. 12 indexed citations

Husser, Christophe, et al.. (2019). Studying the Biotransformation of Phosphorothioate-Containing Oligonucleotide Drugs by LC-MS. Methods in molecular biology. 2036. 307–315. 4 indexed citations

10.

Brink, Andreas, et al.. (2017). Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry. PLoS ONE. 12(11). e0186461–e0186461. 14 indexed citations

11.

Fontaine, Fabien, et al.. (2016). Enhancing Throughput of Glutathione Adduct Formation Studies and Structural Identification Using a Software-Assisted Workflow Based on High-Resolution Mass Spectrometry (HRMS) Data. 1(1). 1–12. 1 indexed citations

12.

Brink, Andreas, et al.. (2014). Post‐acquisition analysis of untargeted accurate mass quadrupole time‐of‐flight MS ^E data for multiple collision‐induced neutral losses and fragment ions of glutathione conjugates. Rapid Communications in Mass Spectrometry. 28(24). 2695–2703. 31 indexed citations

13.

Brink, Andreas, Ingrid Richter, Ursula Lutz, et al.. (2009). Biological significance of DNA adducts: Comparison of increments over background for various biomarkers of genotoxicity in L5178Y tk+/− mouse lymphoma cells treated with hydrogen peroxide and cumene hydroperoxide. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 678(2). 123–128. 10 indexed citations

14.

Stopper, Helga, Udo Bahner, Nicole Schupp, et al.. (2008). Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Nephrology Dialysis Transplantation. 23(10). 3272–3279. 44 indexed citations

15.

Kellert, Marco, Andreas Brink, Ingrid Richter, J. Schlatter, & Werner K. Lutz. (2008). Tests for genotoxicity and mutagenicity of furan and its metabolite cis-2-butene-1,4-dial in L5178Y tk+/− mouse lymphoma cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 657(2). 127–132. 45 indexed citations

16.

Brink, Andreas, et al.. (2007). Homocysteine exerts genotoxic and antioxidative effects in vitro. Toxicology in Vitro. 21(8). 1402–1408. 11 indexed citations

17.

Brink, Andreas, Berta Schulz, Helga Stopper, & Werner K. Lutz. (2007). Biological significance of DNA adducts investigated by simultaneous analysis of different endpoints of genotoxicity in L5178Y mouse lymphoma cells treated with methyl methanesulfonate. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 625(1-2). 94–101. 13 indexed citations

18.

Brink, Andreas, et al.. (2005). Time-dependent effects of sodium arsenite on DNA breakage and apoptosis observed in the comet assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 603(2). 121–128. 21 indexed citations

19.

Brink, Andreas, Ursula Lutz, Wolfgang Völkel, & Werner K. Lutz. (2005). Simultaneous determination of O6-methyl-2′-deoxyguanosine, 8-oxo-7,8-dihydro-2′-deoxyguanosine, and 1,N6-etheno-2′-deoxyadenosine in DNA using on-line sample preparation by HPLC column switching coupled to ESI-MS/MS. Journal of Chromatography B. 830(2). 255–261. 39 indexed citations

20.

Brink, Andreas, et al.. (2004). Biotests zur Wirkung von insektenresistentem Bacillus thuringiensis-Mais auf den pupalen Hyperparasitoiden Tetrastichus howardi (Hymenoptera: Eulophidae). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact